KALA
Price:
$0.964
Market Cap:
$6.77M
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Industry
Biotechnology
IPO Date
2017-07-20
Stock Exchange
NASDAQ
Ticker
KALA
According to KALA BIO, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.17. This represents a change of -77.80% compared to the average of -0.77 of the last 4 quarters.
The mean historical PE Ratio of KALA BIO, Inc. over the last ten years is -4.81. The current -0.17 PE Ratio has changed 253.73% with respect to the historical average. Over the past ten years (40 quarters), KALA's PE Ratio was at its highest in in the September 2022 quarter at 0.14. The PE Ratio was at its lowest in in the December 2015 quarter at -22.74.
Average
-4.81
Median
-1.65
Minimum
-19.16
Maximum
-0.40
Discovering the peaks and valleys of KALA BIO, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 154.41%
Maximum Annual PE Ratio = -0.40
Minimum Annual Increase = -83.75%
Minimum Annual PE Ratio = -19.16
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.99 | 146.59% |
| 2023 | -0.40 | -68.83% |
| 2022 | -1.29 | 133.94% |
| 2021 | -0.55 | -83.75% |
| 2020 | -3.40 | 154.41% |
| 2019 | -1.34 | -31.75% |
| 2018 | -1.96 | -78.96% |
| 2017 | -9.32 | -3.28% |
| 2016 | -9.64 | -49.70% |
| 2015 | -19.16 | -17.05% |
The current PE Ratio of KALA BIO, Inc. (KALA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.90
5-year avg
-1.33
10-year avg
-4.81
KALA BIO, Inc.’s PE Ratio is greater than AIM ImmunoTech Inc. (-0.20), less than Oragenics, Inc. (-0.00), less than Pasithea Therapeutics Corp. (-0.00), greater than VYNE Therapeutics Inc. (-0.48), greater than Can-Fite BioPharma Ltd. (-1.20), greater than Ensysce Biosciences, Inc. (-0.43), less than Impact BioMedical Inc. (-0.15), greater than XTL Biopharmaceuticals Ltd. (-4.14), greater than Soligenix, Inc. (-0.50), greater than Abpro Corporation (-1.19),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.20 | $4.19M | |
| -0.00 | $3.55M | |
| -0.00 | $8.63M | |
| -0.48 | $6.24M | |
| -1.20 | $3.65M | |
| -0.43 | $3.86M | |
| -0.15 | $5.88M | |
| -4.14 | $4.76M | |
| -0.50 | $16.43M | |
| -1.19 | $12.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KALA BIO, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like KALA BIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is KALA BIO, Inc.'s PE Ratio?
How is the PE Ratio calculated for KALA BIO, Inc. (KALA)?
What is the highest PE Ratio for KALA BIO, Inc. (KALA)?
What is the 3-year average PE Ratio for KALA BIO, Inc. (KALA)?
What is the 5-year average PE Ratio for KALA BIO, Inc. (KALA)?
How does the current PE Ratio for KALA BIO, Inc. (KALA) compare to its historical average?